首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi

市場調查報告書

商品編碼

2050608

外泌體診斷和治療市場：按類型、產品類型、服務、來源、應用、最終用戶和地區分類

Exosomes Diagnostic and Therapeutic Market, By Type, By Product & Service, By Source, By Application, By End User, By Geography

出版日期: 2026年03月30日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，外泌體診斷和治療市場規模將達到 1.103 億美元，到 2033 年將達到 3.707 億美元。預計從 2026 年到 2033 年，該市場將以 18.9% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	1.103億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	18.90%	2033年市場規模預測：	3.707億美元

近年來，全球外吐小體診斷和治療市場經歷了顯著成長。外吐小體是奈米級細胞外囊泡，可作為蛋白質、脂質和核酸等生物分子的載體。它們在細胞間通訊和免疫反應中發揮著至關重要的作用。外吐小體在包括癌症、神經系統疾病和心血管疾病在內的多種疾病的診斷和治療中應用日益廣泛，推動了這個市場的成長。研究人員和醫療保健行業相關人員正日益利用外泌體在微創液態生物檢體、藥物遞送解決方案和再生醫學發展方面的潛力。分離和表徵技術的進步進一步擴展了外泌體研究和臨床應用的範圍。

市場動態

外泌體診斷和治療的關鍵市場促進因素包括：對非侵入性診斷日益成長的需求、目標疾病盛行率不斷上升、外泌體治療方法相較於傳統藥物的優勢以及技術進步。然而，分離技術和表徵工具的高成本以及缺乏標準化限制了市場成長。另一方面，可及性的提高和技術的持續改進正在創造新的機會。抗衰老治療、不孕症治療和感染疾病控制等領域的新應用也被認為前景廣闊。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究基於以下參數分析了全球外泌體診斷和治療市場的主要參與者：公司亮點、產品系列、關鍵亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份《全球外泌體診斷與治療市場報告》旨在為業界的各類相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析全球外泌體診斷和治療市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第10章競爭格局

Thermo Fisher Scientific
NanoSomix
NX Pharmagen
Malvern Instruments
Capricor Therapeutic
Exosome Diagnostics
Exiqon A/S
System Biosciences
Exosome Sciences
Aegle Therapeutic
AMS Biotechnology
Miltenyi Biotec
Codiak BioSciences Inc.
Lonza Group（HansaBioMed Life Sciences Ltd.）
AcouSort AB
Aethlon Medical, Inc.
AGC Biologics
Anjarium Biosciences AG
Aruna Bio
Brexogen
Capricor Therapeutics
Cells for Cells
Ciloa
ConvEyXO

第11章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第12章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI7310

Exosomes Diagnostic and Therapeutic Market is estimated to be valued at USD 110.3 Mn in 2026 and is expected to reach USD 370.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 18.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 110.3 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	18.90%	2033 Value Projection:	USD 370.7 Mn

The global exosomes diagnostic and therapeutic market has been witnessing significant growth in the recent years. Exosomes are nano-sized extracellular vesicles that act as carriers of biomolecules like proteins, lipids, and nucleic acids. They play an important role in cell-to-cell communication and immune response. The growing application of exosomes in diagnosis and treatment of various diseases like cancer, neurological disorders, and cardiovascular conditions is driving the growth of this market. Researchers and healthcare industry players are increasingly leveraging the potential of exosomes for developing minimally invasive liquid biopsies, drug delivery solutions, and regenerative therapies. Advancements in isolation and characterization techniques are further expanding the scope of research as well as clinical use of exosomes.

Market Dynamics

The key drivers propelling the exosomes diagnostic and therapeutic market include growing demand for non-invasive diagnostic methods, increasing prevalence of target diseases, advantages of exosome-based therapies over conventional drugs, and technological advancements. However, high costs associated with isolation techniques and characterization tools, as well as lack of standardization are limiting the market growth. On the positive side, improved access and ongoing refinements are creating new opportunities. Emerging applications in anti-aging therapeutics, fertility management, and infection control also hold promise.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global exosomes diagnostic and therapeutic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific, NanoSomix, NX Pharmagen, , Malvern Instruments, Capricor Therapeutic, Exosome Diagnostics, Exiqon A/S, System Biosciences, Exosome Sciences, Aegle Therapeutic, AMS Biotechnology, Miltenyi Biotec, Codiak BioSciences Inc., Lonza Group (HansaBioMed Life Sciences Ltd.), AcouSort AB, Aethlon Medical, Inc., AGC Biologics, Anjarium Biosciences AG, Aruna Bio, Brexogen, Capricor Therapeutics, Cells for Cells, Ciloa, ConvEyXO
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global exosomes diagnostic and therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global exosomes diagnostic and therapeutic market.

Market Segmentation

By Type Insights (Revenue, USD Mn, 2021 - 2033)
Exosome Diagnostics
Exosome Therapeutics
By Product & Service Insights (Revenue, USD Mn, 2021 - 2033)
Instruments & Services
Kits & Reagents
By Source Insights (Revenue, USD Mn, 2021 - 2033)
Stem Cells
Blood & Blood Plasma
Urine
Other Sources
By Application Insights (Revenue, USD Mn, 2021 - 2033)
Cancer
Dermatological Diseases
Musculoskeletal Disorders
Cardiovascular Diseases
Others
By End User Insights (Revenue, USD Mn, 2021 - 2033)
Hospitals & Diagnostic Centers
Clinics and Physician Settings
Academic and Research Institutions
Contract Research Organizations
Others
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Thermo Fisher Scientific
NanoSomix
NX Pharmagen
Malvern Instruments
Capricor Therapeutic
Exosome Diagnostics
Exiqon A/S
System Biosciences
Exosome Sciences
Aegle Therapeutic
AMS Biotechnology
Miltenyi Biotec
Codiak BioSciences Inc.
Lonza Group (HansaBioMed Life Sciences Ltd.)
AcouSort AB
Aethlon Medical, Inc.
AGC Biologics
Anjarium Biosciences AG
Aruna Bio
Brexogen
Capricor Therapeutics
Cells for Cells
Ciloa
ConvEyXO

1. RESEARCH OBJECTIVES AND ASSUMPTIONS

Research Objectives
Assumptions
Abbreviations

2. MARKET PURVIEW

Report Description
- Market Definition and Scope
Executive Summary
- Global Exosomes Diagnostic and Therapeutic Market, By Type
- Global Exosomes Diagnostic and Therapeutic Market, By Product & Service
- Global Exosomes Diagnostic and Therapeutic Market, By Source
- Global Exosomes Diagnostic and Therapeutic Market, By Application
- Global Exosomes Diagnostic and Therapeutic Market, By End User
- Global Exosomes Diagnostic and Therapeutic Market, By Region

3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Exosomes Diagnostic and Therapeutic Market, By Type, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Exosome Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Exosome Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. Global Exosomes Diagnostic and Therapeutic Market, By Product & Service, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Instruments & Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Kits & Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Exosomes Diagnostic and Therapeutic Market, By Source, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Blood & Blood Plasma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Urine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Other Sources
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

7. Global Exosomes Diagnostic and Therapeutic Market, By Application, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Dermatological Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Musculoskeletal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

8. Global Exosomes Diagnostic and Therapeutic Market, By End User, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Hospitals & Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Clinics and Physician Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

9. Global Exosomes Diagnostic and Therapeutic Market, By Region, 2026 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2026 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

10. COMPETITIVE LANDSCAPE

Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
NanoSomix
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
NX Pharmagen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Malvern Instruments
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Capricor Therapeutic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Exosome Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Exiqon A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
System Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Exosome Sciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Aegle Therapeutic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AMS Biotechnology
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Miltenyi Biotec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Codiak BioSciences Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lonza Group (HansaBioMed Life Sciences Ltd.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AcouSort AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Aethlon Medical, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AGC Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Anjarium Biosciences AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Aruna Bio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Brexogen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Capricor Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cells for Cells
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ciloa
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ConvEyXO
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies